BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 9384588)

  • 21. Involvement of the Ets family factor PU.1 in the activation of immunoglobulin promoters.
    Schwarzenbach H; Newell JW; Matthias P
    J Biol Chem; 1995 Jan; 270(2):898-907. PubMed ID: 7822329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
    Babb R; Cleary MA; Herr W
    Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin V kappa promoter.
    Atchison ML; Delmas V; Perry RP
    EMBO J; 1990 Oct; 9(10):3109-17. PubMed ID: 2120037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination.
    Kim EC; Edmonston CR; Wu X; Schaffer A; Casali P
    J Biol Chem; 2004 Oct; 279(40):42258-69. PubMed ID: 15252056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.
    Ezashi T; Ghosh D; Roberts RM
    Mol Cell Biol; 2001 Dec; 21(23):7883-91. PubMed ID: 11689681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration.
    Tomilin A; Reményi A; Lins K; Bak H; Leidel S; Vriend G; Wilmanns M; Schöler HR
    Cell; 2000 Dec; 103(6):853-64. PubMed ID: 11136971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. POU domain factors in neural development.
    Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
    Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.
    Kemler I; Bucher E; Seipel K; Müller-Immerglück MM; Schaffner W
    Nucleic Acids Res; 1991 Jan; 19(2):237-42. PubMed ID: 2014164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The virtuoso of versatility: POU proteins that flex to fit.
    Phillips K; Luisi B
    J Mol Biol; 2000 Oct; 302(5):1023-39. PubMed ID: 11183772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters.
    Pierani A; Heguy A; Fujii H; Roeder RG
    Mol Cell Biol; 1990 Dec; 10(12):6204-15. PubMed ID: 2123291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of chicken octamer-binding proteins demonstrates that POU domain-containing homeobox transcription factors have been highly conserved during vertebrate evolution.
    Petryniak B; Staudt LM; Postema CE; McCormack WT; Thompson CB
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1099-103. PubMed ID: 1967834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family-specific differences in transcription efficiency of Ig heavy chain promoters.
    Buchanan KL; Smith EA; Dou S; Corcoran LM; Webb CF
    J Immunol; 1997 Aug; 159(3):1247-54. PubMed ID: 9233620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone H2B gene transcription during Xenopus early development requires functional cooperation between proteins bound to the CCAAT and octamer motifs.
    Hinkley C; Perry M
    Mol Cell Biol; 1992 Oct; 12(10):4400-11. PubMed ID: 1406629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.
    Tang H; Sharp PA
    Immunity; 1999 Nov; 11(5):517-26. PubMed ID: 10591177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5.
    Bertolino E; Reddy K; Medina KL; Parganas E; Ihle J; Singh H
    Nat Immunol; 2005 Aug; 6(8):836-43. PubMed ID: 16025120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct.
    González MI; Tovaglieri A; Robins DM
    Mol Cell Endocrinol; 2002 Apr; 190(1-2):39-49. PubMed ID: 11997177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1.
    Shore P; Dietrich W; Corcoran LM
    Nucleic Acids Res; 2002 Apr; 30(8):1767-73. PubMed ID: 11937630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
    Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
    J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.
    Ren X; Siegel R; Kim U; Roeder RG
    Mol Cell; 2011 May; 42(3):342-55. PubMed ID: 21549311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell development and immunoglobulin transcription in Oct-1-deficient mice.
    Wang VE; Tantin D; Chen J; Sharp PA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2005-10. PubMed ID: 14762167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.